About Syncardia systems, inc.
SynCardia Systems, Inc. is a leading medical device company that specializes in manufacturing the SynCardia temporary Total Artificial Heart for patients with end-stage, biventricular heart failure who are in need of a donor heart transplant. The company was founded in 2001 and has since been dedicated to providing life-saving solutions to patients suffering from severe heart conditions.
The SynCardia Total Artificial Heart is the world's first and only FDA-approved temporary Total Artificial Heart. It is designed to replace both failing ventricles of a patient's heart and provide immediate, life-saving support until a suitable donor heart becomes available for transplantation. The device has been used successfully in over 1,700 patients worldwide and has saved countless lives.
One of the key advantages of the SynCardia Total Artificial Heart is its portability. Unlike other artificial hearts that require large external consoles or power sources, the SynCardia device can be powered by an external driver that can be carried by the patient or placed on a wheeled cart for easy transport. This allows patients to move around freely while waiting for their transplant surgery.
In addition to manufacturing the SynCardia Total Artificial Heart, Syncardia Systems also provides comprehensive training and support services to healthcare professionals who use their devices. This includes on-site training programs, online resources, and technical support services available 24/7.
Syncardia Systems' commitment to innovation has led them to develop several new products aimed at improving patient outcomes and quality of life. One such product is their Freedom® Portable Driver System which allows patients with an implanted SynCardia Total Artificial Heart to leave the hospital and return home while they wait for their transplant surgery.
Another innovative product developed by Syncardia Systems is their Companion 2 Hospital Driver System which provides hospitals with an alternative power source for driving multiple artificial hearts simultaneously during emergencies or when there are limited resources available.
Overall, Syncardia Systems' dedication towards developing innovative medical devices that save lives makes them one of the most respected companies in this field today. Their commitment towards providing comprehensive training programs along with excellent customer service ensures that healthcare professionals have access to all necessary resources required when using these lifesaving devices.
In conclusion, if you or someone you know suffers from end-stage biventricular heart failure requiring a donor transplant then look no further than Syncardia systems inc., as they offer some of the most advanced medical technologies available today!